We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 14th:
Anheuser-Busch InBev SA/NV (BUD - Free Report) : This brewing companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.
Aerojet Rocketdyne Holdings, Inc. : This manufacturer of aerospace and defense products and systems has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.8% over the last 60 days.
Aerojet Rocketdyne Holdings, Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 14th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 14th:
Anheuser-Busch InBev SA/NV (BUD - Free Report) : This brewing companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.
Anheuser-Busch InBev SA/NV Price and Consensus
Anheuser-Busch InBev SA/NV price-consensus-chart | Anheuser-Busch InBev SA/NV Quote
Anheuser-Busch's shares gained 8% over the last one month compared to S&P 500’s fall of -2.9%. The company possesses a Momentum Score of A.
Anheuser-Busch InBev SA/NV Price
Anheuser-Busch InBev SA/NV price | Anheuser-Busch InBev SA/NV Quote
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.
Aercap Holdings N.V. Price and Consensus
Aercap Holdings N.V. price-consensus-chart | Aercap Holdings N.V. Quote
AerCap's shares gained 3.3% over the last one month. The company possesses a Momentum Score of A.
Aercap Holdings N.V. Price
Aercap Holdings N.V. price | Aercap Holdings N.V. Quote
Aerojet Rocketdyne Holdings, Inc. : This manufacturer of aerospace and defense products and systems has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.8% over the last 60 days.
Aerojet Rocketdyne Holdings, Inc. Price and Consensus
Aerojet Rocketdyne Holdings, Inc. price-consensus-chart | Aerojet Rocketdyne Holdings, Inc. Quote
Aerojet’s shares gained 6.8% over the last one month. The company possesses a Momentum Score of B.
Aerojet Rocketdyne Holdings, Inc. Price
Aerojet Rocketdyne Holdings, Inc. price | Aerojet Rocketdyne Holdings, Inc. Quote
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote
ACADIA’s shares gained 10.2% over the last one month. The company possesses a Momentum Score of B.
ACADIA Pharmaceuticals Inc. Price
ACADIA Pharmaceuticals Inc. price | ACADIA Pharmaceuticals Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>